AstraZeneca sues generic drug maker Teva

AstraZeneca has filed suit for patent infringement against Israeli generic drug maker Teva, which announced plans to formulate a generic version of AstraZeneca's $2 billion schizophrenia drug Seroquel. AstraZeneca's suit prevents the FDA from approving Teva's generic Seroquel until a settlement is reached, a process that could take years.

- read this AP article [1] for more on the suit